FDA Orders Device Companies to Study Risks of Surgical Mesh Implants

The Food and Drug Administration has ordered medical device companies to study and determine possible risks from their implantable surgical mesh products, according to a New York Times report.

Advertisement

Read the full report in Becker’s Hospital Review on implantable surgical mesh.

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Uncategorized

Advertisement

Comments are closed.